Antibacterial noncytotoxic chitosan coatings on polytetrafluoroethylene films by plasma grafting for medical device applications
Antibacterial noncytotoxic chitosan coatings on polytetrafluoroethylene films by plasma grafting for medical device applications
Authors
Vaz, Juliana M.
Taketa, Thiago B.
Hernandez Montelongo, Jacobo
Fiuza, Larissa M. C. G.
Rodrigues, Cristiano
Beppu, Marisa M.
Vieira, Rodrigo S.
Taketa, Thiago B.
Hernandez Montelongo, Jacobo
Fiuza, Larissa M. C. G.
Rodrigues, Cristiano
Beppu, Marisa M.
Vieira, Rodrigo S.
Profesor GuĆa
Authors
Date
Datos de publicaciĆ³n:
10.1007/s11998-021-00560-3
JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH,Vol.,,2022
JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH,Vol.,,2022
Tipo de recurso
Keywords
Materia geogrƔfica
Collections
Abstract
Chitosan is an exciting alternative for the development of coating-surfaces due to its large action spectrum against pathogenic microorganisms. However, to produce a stable coating with effective antibacterial action, a compromise between deacetylation degree (DD) and molecular weight (MW) is essential. Four chitosan samples were characterized regarding Mw and DD and correlated with the minimum and bactericide concentrations against E. coli, P. aeruginosa, and S. aureus. CHI80MW (79.7% DD and 7.0 x 10(5) Da) showed the best antibacterial effect and was selected to functionalize polytetrafluoroethylene (PTFE) surfaces by plasma. CHI80MW was grafted onto the PTFE surfaces using two different spacer molecules: poly(ethylene glycol) bis (carboxymethyl) ether (PEG) and poly(ethylene-alt-maleic anhydride) (PA). PTFE-Plasma-PA-CHI80MW exhibited a coating with more attached chitosan and better antibacterial action if compared to PTFE-Plasma-PEG-CHI80MW: after 8 h, PTFE-Plasma-PEG-CHI80MW presented a bacterial reduction of 25-30% for the three bacterial strains, and PTFE-Plasma-PA-CHI80MW reduced them to 77-90%. Moreover, cytotoxicity tests showed that PTFE-Plasma-PA-CHI80MW samples were compatible with human fibroblasts.